Edward Hurwitz

Edward M.
Hurwitz is the founder of Arialys Therapeutics, Inc., founded in 2021, serving as Director since 2021.
Mr. Hurwitz was the founder of ViewPoint Therapeutics, Inc., founded in 2014, where the title held was Director.
Mr. Hurwitz is the founder of Precision BioVentures LLC, founded in 2014, serving as Managing Director since 2014.
Current jobs include Chairman at Rekindle Therapeutics, Inc., Director at Alta BioPharma Management III LLC, Independent Director at MacroGenics, Inc. since 2004, Director at ReCode Therapeutics, Inc., Independent Director at Dyne Therapeutics, Inc. since 2018, Director at Protego Biopharma, Inc., Managing Director at MPM BioImpact LLC since 2017, Manager at Alta Embarcadero Biopharma Partners III LLC, and Chief Financial Officer at Turmeric Acquisition Corp.
Former jobs include Chairman at Biointervene, Inc., Director at Alta Partners Management Co. LP, Director at FoldRx Pharmaceuticals LLC, Independent Director at Sunesis Pharmaceuticals, Inc. from 2011 to 2013, Director at Taligen Therapeutics, Inc., Independent Director at CARA Therapeutics, Inc. from 2006 to 2014, Director at Avid Radiopharmaceuticals, Inc., Director at Alta Partners VIII LP from 2002 to 2014, Director at Calistoga Pharmaceuticals, Inc., Independent Director at Beacon Therapeutics (USA), Inc. from 2012 to 2022, Director at Alta Partners LP from 2002 to 2014, Director at Alta Biopharma Iii LP from 2002 to 2014, and Chief Financial Officer & Senior Vice President at Affymetrix, Inc. from 1997 to 2002.
Education includes an undergraduate degree from Cornell University conferred in 1985, an MBAistration from Haas School of Business conferred in 1990, and graduate studies at Berkeley Law University of California.